Citations (16)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (4)
Marwa H. Shukr, Soha Ismail, Ghada G. El-Hossary & Amany H. El-Shazly. (2022) Spanlastics nanovesicular ocular insert as a novel ocular delivery of travoprost: optimization using Box–Behnken design and in vivo evaluation. Journal of Liposome Research 32:4, pages 354-364.
Read now
Read now
Andreas Katsanos, Ivano Riva, Banu Bozkurt, Gábor Holló, Luciano Quaranta, Francesco Oddone, Murat Irkec, Gordon N. Dutton & Anastasios G. Konstas. (2022) A new look at the safety and tolerability of prostaglandin analogue eyedrops in glaucoma and ocular hypertension. Expert Opinion on Drug Safety 21:4, pages 525-539.
Read now
Read now
Tadashi Nakano, Shiro Mizoue, Nobuo Fuse, Aiko Iwase, Shun Matsumoto & Keiji Yoshikawa. (2017) Fixed combination of travoprost and timolol maleate reduces intraocular pressure in Japanese patients with primary open-angle glaucoma or ocular hypertension: analysis by prostaglandin analogue. Clinical Ophthalmology 11, pages 55-61.
Read now
Read now
Shamira A Perera, Daniel SW Ting, Monisha E Nongpiur, Paul T Chew, Maria Cecilia D Aquino, Chelvin CA Sng, Sue-Wei Ho & Tin Aung. (2016) Feasibility study of sustained-release travoprost punctum plug for intraocular pressure reduction in an Asian population. Clinical Ophthalmology 10, pages 757-764.
Read now
Read now
Articles from other publishers (12)
S. Yu. Petrov, L. V. Yakubova, L. V. Vasilenkova, O. M. Filippova, A. N. Zhuravleva & V. I. Kotelin. (2022) Preservative free travoprost and timolol fixed combination in the initial treatment of primary glaucoma: an assessment of hypotensive efficiency and safety. Russian Ophthalmological Journal 14:4, pages 79-84.
Crossref
Crossref
Ziyan Cai, Mengdan Cao, Ke Liu & Xuanchu Duan. (2021) Analysis of the Responsiveness of Latanoprost, Travoprost, Bimatoprost, and Tafluprost in the Treatment of OAG/OHT Patients. Journal of Ophthalmology 2021, pages 1-12.
Crossref
Crossref
Marwa H. Shukr, Soha Ismail, Ghada G. El-Hossary & Amany H. El-Shazly. (2021) Design and evaluation of mucoadhesive in situ liposomal gel for sustained ocular delivery of travoprost using two steps factorial design. Journal of Drug Delivery Science and Technology 61, pages 102333.
Crossref
Crossref
Ayman Ismail, Maha Nasr & Omaima Sammour. (2020) Nanoemulsion as a feasible and biocompatible carrier for ocular delivery of travoprost: Improved pharmacokinetic/pharmacodynamic properties. International Journal of Pharmaceutics 583, pages 119402.
Crossref
Crossref
Carter W. Lim, Vlad Diaconita, Eddie Liu, Nicholas Ault, Daniel Lizotte, Mary Nguyen & Cindy M.L. Hutnik. (2020) Effect of 6-week washout period on intraocular pressure following chronic prostaglandin analogue treatment: a randomized controlled trial. Canadian Journal of Ophthalmology 55:2, pages 143-151.
Crossref
Crossref
Peter G Klimko & Najam A Sharif. (2018) Discovery, characterization and clinical utility of prostaglandin agonists for the treatment of glaucoma. British Journal of Pharmacology 176:8, pages 1051-1058.
Crossref
Crossref
Jarkko Rautio, Nicholas A. Meanwell, Li Di & Michael J. Hageman. (2018) The expanding role of prodrugs in contemporary drug design and development. Nature Reviews Drug Discovery 17:8, pages 559-587.
Crossref
Crossref
S. Yu. Petrov, I. V. Kozlova, V. S. Zinina, A. V. Volzhanin & M. V. Kravchik. (2018) Hypotensive efficacy of bimatoprost in monotherapy of primary open-angle glaucoma. Vestnik oftal'mologii 134:5, pages 208.
Crossref
Crossref
Gábor Holló, Andreas Katsanos, Kostas G. Boboridis, Murat Irkec & Anastasios G. P. Konstas. (2017) Preservative-Free Prostaglandin Analogs and Prostaglandin/Timolol Fixed Combinations in the Treatment of Glaucoma: Efficacy, Safety and Potential Advantages. Drugs 78:1, pages 39-64.
Crossref
Crossref
El Roy Dixon, Theresa Landry, Subha Venkataraman, Nancy Gustafson, Craig Salem, Yasmin Bradfield, Leyla Ali Aljasim & Robert Feldman. (2017) A 3-month safety and efficacy study of travoprost 0.004% ophthalmic solution compared with timolol in pediatric patients with glaucoma or ocular hypertension. Journal of American Association for Pediatric Ophthalmology and Strabismus 21:5, pages 370-374.e1.
Crossref
Crossref
Tomoko Naito, Shinichi Okuma, Mikio Nagayama, Shiro Mizoue, Mineo Ozaki, Koji Namiguchi, Kazuhisa Miyamoto, Masaki Tanito & Keiji Yoshikawa. (2016) Sustainability of Intraocular Pressure Reduction of Travoprost Ophthalmic Solution in Subjects with Normal Tension Glaucoma. Advances in Therapy 33:3, pages 435-446.
Crossref
Crossref
Paul Harasymowycz, Catherine Birt, Patrick Gooi, Lisa Heckler, Cindy Hutnik, Delan Jinapriya, Lesya Shuba, David Yan & Radmila Day. (2016) Medical Management of Glaucoma in the 21st Century from a Canadian Perspective. Journal of Ophthalmology 2016, pages 1-22.
Crossref
Crossref